⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
The Skin of Color Society (SOCS) Reports an Impactful Year of Progress, Expansion, and Innovation Toward Advancing Knowledge and Excellence in Patient Care
prnewswire.com
JNJ
LLY
SNY
REGN
ABBV
AERO
BIIB
GALT
TAK
ELMD
PFE
SUN
INCY
BMY
ARQT
UCB
Debbie's Dream Foundation: Curing Stomach Cancer Thanks Its 2025 Industry Partners for Advancing Critical Programs and Patient Support
prnewswire.com
AMGN
BMY
ARCX
AZN
GILD
JAZZ
LLY
MRK
ASTL
THTX
Best Zepbound Alternative for 2026? FDA Regulatory Timeline Reshapes Telehealth Tirzepatide Access as SkinnyRx Platform Lists Compounded Options
globenewswire.com
LLY
Ozempatch: Do Herbal Weight Loss Patches Actually Work? 2026 Consumer Analysis as GLP-1 Patch Ads Surge During Resolution Season
globenewswire.com
NVO
LLY
Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways
globenewswire.com
NVO
LLY
Capital Square Launches New Active Living DST Offering in Richmond's Short Pump Submarket
prnewswire.com
LLY
Best Peptides for Weight Loss 2026: Industry Analysis Examines Compounded GLP-1 Telehealth Access and Pricing Transparency
globenewswire.com
NVO
LLY
GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: Growing Shift of Weekly Injectables Toward Orals and Multi-Agonists - ResearchAndMarkets.com
businesswire.com
LLY
NVO
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly USA - English USA - English APAC - English
prnewswire.com
LLY
Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
prnewswire.com
LLY